High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. (Q55470753)

12 July 2018

title

High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. (English)

1 reference

12 July 2018

adaptive radiation therapy

main subject

0 references

3

Keiichi Nakagawa

1 reference

12 July 2018

author name string

Minoru Tanaka

1

1 reference

12 July 2018

Yasushi Ino

2

1 reference

12 July 2018

Masao Tago

4

1 reference

12 July 2018

Tomoki Todo

5

1 reference

12 July 2018

publication date

1 December 2005

1 reference

12 July 2018

Lancet Oncology Commission

published in

1 reference

12 July 2018

volume

6

1 reference

12 July 2018

issue

12

1 reference

12 July 2018

page(s)

953-960

1 reference

12 July 2018

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

cites work

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Effects of ACNU and radiotherapy on malignant glioma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Molecular and cellular pathology of intrinsic brain tumours

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Radiation therapy for malignant astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas: assessing the tolerability of a new radiotherapy regimen

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

High-Dose Conformal Radiotherapy Influenced the Pattern of Failure But Did Not Improve Survival in Glioblastoma Multiforme

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Work in progress: treatment planning system for conformation radiotherapy.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02)

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Glioma invasion in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(05)70395-8

7 January 2021

10.1016/S1470-2045(05)70395-8

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018